v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 710 $ 715
Restricted cash and cash equivalents 42 42
Accounts and notes receivable – net 1,699 1,669
Inventories 1,209 1,172
Prepaid and other current assets 130 121
Assets of discontinued operations 1,853 1,856
Total current assets 5,643 5,575
Property, plant and equipment – net of accumulated depreciation (March 31, 2026 - $3,634; December 31, 2025 - $3,565) 3,426 3,464
Other Assets    
Goodwill 7,865 7,915
Other intangible assets 2,860 2,936
Investments and noncurrent receivables 452 432
Deferred income tax assets 264 282
Deferred charges and other assets 939 971
Total other assets 12,380 12,536
Total Assets 21,449 21,575
Current Liabilities    
Short-term borrowings 40 60
Accounts payable 882 995
Income taxes payable 49 54
Accrued and other current liabilities 833 882
Liabilities of discontinued operations 299 314
Total current liabilities 2,103 2,305
Long-Term Debt 3,132 3,134
Other Noncurrent Liabilities    
Deferred income tax liabilities 378 405
Pension and other post-employment benefits – noncurrent 414 432
Other noncurrent obligations 1,184 1,196
Total other noncurrent liabilities 1,976 2,033
Total Liabilities 7,211 7,472
Commitments and contingent liabilities
Stockholders' Equity    
Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2026: 409,867,418 shares; 2025: 409,195,445 shares) 4 4
Additional paid-in capital 38,849 38,718
Accumulated deficit (24,201) (24,278)
Accumulated other comprehensive loss (612) (525)
Total DuPont stockholders' equity 14,040 13,919
Noncontrolling interests 198 184
Total equity 14,238 14,103
Total Liabilities and Equity $ 21,449 $ 21,575